Testing effectiveness (Phase 2)Study completedNCT01524926
What this trial is testing
CREATE: Cross-tumoral Phase 2 With Crizotinib
Who this might be right for
Locally Advanced and/or Metastatic Anaplastic Large Cell LymphomaLocally Advanced and/or Metastatic Inflammatory Myofibroblastic TumorLocally Advanced and/or Metastatic Papillary Renal Cell Carcinoma Type 1+3 more
European Organisation for Research and Treatment of Cancer - EORTC 582